Table 3.

Summary of Repeat Assessments by Remission

	Subject Characteristic
	Remission			Failed Medication Taper
		Value at:			Value at:
Test	N=	Baseline	Last Follow-Up	N=	Baseline	Last Follow-Up
Nerve Ultrasound: Average Nerve Size Index	13	158% (82–289)	114%** (87–158)	10	173% (111–461%)	203% (137–388)
Grip Strength	12	231N (4–454)	405N** (107–476)	7	311N (85–632)	298N (245–636)
Electro-diagnostics	10	Demyelinating Features Present		10	Demyelinating Features Present
		N=10†	N=3*		N=9†	N=9

^*P=0.02,

^**P≤0.009 compared to baseline. All values median (range) unless otherwise specified.

^†includes baseline studies performed prior to initial nerve ultrasound. Demyelinating features of motor nerve conduction studies include conduction block, very slowed conduction velocity, very prolonged distal latency, or increased temporal dispersion.²¹